D-0601-2018 Class II Terminated
FDA drug recall D-0601-2018 was initiated by Hetero Labs Limited Unit V on Feb 13, 2018 and is designated Class II. Reason for recall: Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famciclovir complaint… The recall status is terminated (terminated Feb 18, 2021). Affected quantity: 1764 60-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 21, 2018
- Initiation Date
- Feb 13, 2018
- Termination Date
- Feb 18, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1764 60-count bottles
Product description
Valganciclovir Tablets, USP, 450 mg, 60-count bottle, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By: Hetero Hetero Labs Limit Unit V Pollypally Jadcherla Mahaboob Nagar - 509 301 India. NDC # 31722-832-60
Reason for recall
Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famciclovir complaint batch (D-0415-2018).
Distribution pattern
NJ and then distributed Nationwide in the USA
Code information
Lot #s VGC17040 & VGC17041, EXP 07/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0601-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026